Delivery Order SPE2DB20D1100-SPE2DB24FA7F9
- Not listed
- This federal contract award, valued at $3,313.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The award is a firm fixed price delivery order for the medication Hemangeol (4.28 mg/ml oral solution, 120 ml), a specialty pharmaceutical product. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML to the Defense Logistics Agency (DLA). The contract, valued at $2,485.20, is a Firm Fixed Price Delivery Order with a completion date of July 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract, valued at $1,242.60, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for $2,485.20 to provide a pharmaceutical product called HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- On January 29, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,631.42 to AmerisourceBergen Drug Corp for the supply of Hemangeol 4.28 mg/ml oral solution (120ml). This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order is scheduled for completion by February 20, 2026, with performance occurring at the contractor's...
- This federal contract award is a $13,722.71 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00...
- This federal contract award, valued at $2,020.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award, valued at $12,775.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. As the prime contractor, Amerisourcebergen Drug Corp will be responsible for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order valued at $2,083.20. The contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, with a performance period through March 18, 2024. The award does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will provide pharmaceutical products and medical supplies to support military treatment...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order valued at $7,491.19. It was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, for the provision of pharmaceutical products and medical supplies in support of military treatment programs and facilities. The award is part of a larger indefinite delivery contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA7F9Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order valued at $2,485.20. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to supply the pharmaceutical product Hemangeol 4.28 mg/ml oral solution with a 120 ml volume. The award is part of Amerisourcebergen Drug Corp's broader contract vehicles with DLA, including an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025. This IDC serves as the primary means by which Amerisourcebergen provides a wide range of pharmaceuticals and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 3/13/24 |